CNS Recruitment of CD8+ T Lymphocytes Specific for a Peripheral Virus Infection Triggers Neuropathogenesis during Polymicrobial Challenge
Although viruses have been implicated in central nervous system (CNS) diseases of unknown etiology, including multiple sclerosis and amyotrophic lateral sclerosis, the reproducible identification of viral triggers in such diseases has been largely unsuccessful. Here, we explore the hypothesis that viruses need not replicate in the tissue in which they cause disease; specifically, that a peripheral infection might trigger CNS pathology. To test this idea, we utilized a transgenic mouse model in which we found that immune cells responding to a peripheral infection are recruited to the CNS, where they trigger neurological damage. In this model, mice are infected with both CNS-restricted measles virus (MV) and peripherally restricted lymphocytic choriomeningitis virus (LCMV). While infection with either virus alone resulted in no illness, infection with both viruses caused disease in all mice, with ∼50% dying following seizures. Co-infection resulted in a 12-fold increase in the number of CD8+ T cells in the brain as compared to MV infection alone. Tetramer analysis revealed that a substantial proportion (>35%) of these infiltrating CD8+ lymphocytes were LCMV-specific, despite no detectable LCMV in CNS tissues. Mechanistically, CNS disease was due to edema, induced in a CD8-dependent but perforin-independent manner, and brain herniation, similar to that observed in mice challenged intracerebrally with LCMV. These results indicate that T cell trafficking can be influenced by other ongoing immune challenges, and that CD8+ T cell recruitment to the brain can trigger CNS disease in the apparent absence of cognate antigen. By extrapolation, human CNS diseases of unknown etiology need not be associated with infection with any particular agent; rather, a condition that compromises and activates the blood-brain barrier and adjacent brain parenchyma can render the CNS susceptible to pathogen-independent immune attack.
Vyšlo v časopise:
CNS Recruitment of CD8+ T Lymphocytes Specific for a Peripheral Virus Infection Triggers Neuropathogenesis during Polymicrobial Challenge. PLoS Pathog 7(12): e32767. doi:10.1371/journal.ppat.1002462
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002462
Souhrn
Although viruses have been implicated in central nervous system (CNS) diseases of unknown etiology, including multiple sclerosis and amyotrophic lateral sclerosis, the reproducible identification of viral triggers in such diseases has been largely unsuccessful. Here, we explore the hypothesis that viruses need not replicate in the tissue in which they cause disease; specifically, that a peripheral infection might trigger CNS pathology. To test this idea, we utilized a transgenic mouse model in which we found that immune cells responding to a peripheral infection are recruited to the CNS, where they trigger neurological damage. In this model, mice are infected with both CNS-restricted measles virus (MV) and peripherally restricted lymphocytic choriomeningitis virus (LCMV). While infection with either virus alone resulted in no illness, infection with both viruses caused disease in all mice, with ∼50% dying following seizures. Co-infection resulted in a 12-fold increase in the number of CD8+ T cells in the brain as compared to MV infection alone. Tetramer analysis revealed that a substantial proportion (>35%) of these infiltrating CD8+ lymphocytes were LCMV-specific, despite no detectable LCMV in CNS tissues. Mechanistically, CNS disease was due to edema, induced in a CD8-dependent but perforin-independent manner, and brain herniation, similar to that observed in mice challenged intracerebrally with LCMV. These results indicate that T cell trafficking can be influenced by other ongoing immune challenges, and that CD8+ T cell recruitment to the brain can trigger CNS disease in the apparent absence of cognate antigen. By extrapolation, human CNS diseases of unknown etiology need not be associated with infection with any particular agent; rather, a condition that compromises and activates the blood-brain barrier and adjacent brain parenchyma can render the CNS susceptible to pathogen-independent immune attack.
Zdroje
1. AntelJPOwensT 1993 The attraction of adhesion molecules. Ann Neurol 34 123 124
2. ButcherECPickerLJ 1996 Lymphocyte homing and homeostasis. Science 272 60 66
3. MackayCR 1993 Homing of naive, memory and effector lymphocytes. Curr Opin Immunol 5 423 427
4. ChapmanTJCastrucciMRPadrickRCBradleyLMTophamDJ 2005 Antigen-specific and non-specific CD4+ T cell recruitment and proliferation during influenza infection. Virology 340 296 306
5. BakaletzLO 2004 Developing animal models for polymicrobial diseases. Nat Rev Micro 2 552 568
6. BrogdenKAGuthmillerJMTaylorCE 2005 Human polymicrobial infections. Lancet 365 253 255
7. RallGFManchesterMDanielsLRCallahanEMBelmanAR 1997 A transgenic mouse model for measles virus infection of the brain. Proc Natl Acad Sci USA 94 4659 4663
8. LawrenceDMPVaughnMMBelmanARColeJSRallGF 1999 Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and CNS disease. J Virol 73 1795 1801
9. PattersonCELawrenceDMEcholsLARallGF 2002 Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma-interferon dependent. J Virol 76 4497 4506
10. BorrowPOldstoneMBA 1997 Lymphocytic choriomeningitis virus. NathansonN Viral Pathogenesis Philadelphia, PA Lippincott-Raven 593 627
11. BuchmeierMJZajacAJ 1999 Lymphocytic choriomeningitis virus. AhmedRChenI Persistent Viral Infections Chicester, NY John Wiley & Sons 575 605
12. MasopustDMurali-KrishnaKAhmedR 2007 Quantitating the magnitude of the LCMV-specific CD8 T cell response: it's even bigger than we thought. J Virol 81 2002 2011
13. KangSSMcGavernDB 2008 Lymphocytic choriomeningitis infection of the central nervous system. Front Biosci 13 4529 4543
14. MatulloCMO'ReganKJHensleyHCurtisMRallGF 2010 Lymphocytic choriomeningitis virus-induced mortality in mice is triggered by edema and brain herniation. J Virol 84 312 320
15. ShinkaiYRathbunGLamK 1992 RAG-2 deficient mice lack mature lymphocytes owing to the inability to initiate V(D)J rearrangement. Cell 68 855 864
16. KagiDLiedermannBBurkiKSellerPOdermattB 1994 Cytotoxicity mediated by T cells and NK cells is greatly impaired in perforin-deficient mice. Nature 369 31 37
17. LawrenceDMPPattersonCEGalesTLD'OrazioJLVaughnMM 2000 Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation or extracellular virus production. J Virol 74 1908 1918
18. BuchmeierMWelshRDutkoFOldstoneM 1980 The virology and immunobiology of LCMV infection. Adv Immunol 30 275 331
19. OldstoneMBASouthernPJ 1993 Trafficking of activated CTL into the CNS: use of a transgenic model. J Neuroimmunol 46 25 31
20. PattersonCEDaleyJKEcholsLALaneTERallGF 2003 Measles virus infection induces chemokine synthesis by neurons. J Immunol 171 3102 3109
21. ChristensenJEde LemosCMoosTChristensenJPThomsenAR 2006 CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. J Immunol 176 4235 4243
22. ChristensenJENansenAMoosTLuBGerardC 2004 Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3. J Neurosci 24 4849 4858
23. JonckerNTHelftJJacquetAPremelVLantzO 2006 Intratumor CD4 T-cell accumulation requires stronger priming than for expansion and lymphokine secretion. Cancer Res 66 5443 5451
24. JonckerNTMarloieM-AChernyshevaALonchayCCuffS 2006 Antigen-independent accumulation of activated effector/memory T lymphocytes into human and murine tumors. Int J Cancer 118 1205 1214
25. OkamuraHTsutsiHKomatsuTYutsudoMHakuraA 1995 Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 88 91
26. BergRECordesCJFormanJ 2002 Contribution of CD8+ T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur J Immunol 32 2807 2816
27. BergREFormanJ 2006 The role of CD8 T cells in innate immunity and in antigen non-specific protection. Curr Opin Immunol 18 338 343
28. DentonAEDohertyPCTurnerSJLaGrutaNL 2007 IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells. Eur J Immunol 37 368 375
29. vonGeldernMSimmBBraunMWeissEHSchendelDJ 2006 TCR-independent cytokine stimulation induces non-MHC restricted T cell activity and is negatively regulated by HLA class I. Eur J Immunol 36 2347 2358
30. LertmemongkolchaiGCaiGHunterCABancroftGJ 2001 Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol 166 1097 1105
31. NitcheuJBonduelleOCombadiereCTefitMSeilheanD 2003 Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol 170 2221 2228
32. NathansonJAChunLL 1989 Immunological function of the blood-cerebrospinal fluid barrier. Proc Natl Acad Sci USA 86 1684 1688
33. Marelli-BergFMScottDBartokIPeekEDysonJ 2001 Antigen presentation by murine endothelial cells. Transplant Proc 33 315 316
34. WeisNLindhardtBOKronborgGHansenABLaursenAL 2006 Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study. Clin Infect Dis 42 1481 1487
35. RallGF 2003 Measles virus 1998-2002: progress and controversy. Ann Rev Micro 57 343 367
36. RochfordRCannonMJMoormannAM 2005 Endemic Burkitt's lymphoma: a polymicrobial disease? Nat Rev Micro 3 182 187
37. GranBRostamiA 2001 T cells, cytokines, and autoantigens in multiple sclerosis. Curr Neurol Neurosci Rep 1 263 270
38. HuangYHZozulyaALWeidenfellerCMetzIBuckD 2009 Specific central nervous system recruitment of HLA-G+ regulatory T cells in multiple sclerosis. Ann Neurol 66 171 183
39. MoisseKStrongMJ 2006 Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta 1762 1083 1093
40. PapadimitriouDLaVercheVJacquierAIkizBPrzedborskiS 2010 Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol Dis 37 493 502
41. SargsyanSAShearerAJRitchieAMBurgoonMPAndersonS 2010 Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 74 1127 1135
42. MartinCEnbomMSoderstromMFredriksonSDahlH 1997 Absence of seven human herpesviruses, including HHV-6, by PCR in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand 95 280 283
43. KimYJFanYLauriePKimJMRavitsJ 2009 No evidence of HIV pol gene in spinal cord tissue on sporadic ALS by real time RT-PCR. Amyotroph Lateral Scler 11 91 96
44. WalkerMPSchlabergRHaysAPBowserRLipkinWI 2001 Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients. Ann Neurol 49 249 253
45. ConsilvioCVincentAMFeldmanEL 2004 Neuroinflammation, COX-2, and ALS - a dual role? Exper Neurol 187 1 10
46. GrigoriadisNGrigoriadisSPolyzoidouEMilonasIKarussisD 2006 Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autimmune reaction. Clin Neurol Neurosurg 108 241 244
47. StreitWJMrakREGriffinWST 2004 Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 1 1 14
48. GildenDH 2005 Infectious causes of multiple sclerosis. Lancet Neurol 4 195 202
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 12
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Controlling Viral Immuno-Inflammatory Lesions by Modulating Aryl Hydrocarbon Receptor Signaling
- Fungal Virulence and Development Is Regulated by Alternative Pre-mRNA 3′End Processing in
- Epstein-Barr Virus Nuclear Antigen 3C Stabilizes Gemin3 to Block p53-mediated Apoptosis
- Engineered Immunity to Infection